Adherence to continuous positive airway pressure therapy: the challenge to effective treatment
TE Weaver, RR Grunstein - Proceedings of the American Thoracic …, 2008 - atsjournals.org
Despite the high efficacy of continuous positive airway pressure (CPAP) to reverse upper
airway obstruction in sleep apnea, treatment effectiveness is limited by variable adherence …
airway obstruction in sleep apnea, treatment effectiveness is limited by variable adherence …
Gender differences in sleep disorders
V Krishnan, NA Collop - Current opinion in pulmonary medicine, 2006 - journals.lww.com
Gender differences in sleep become apparent after the onset of puberty. Menstrual cycles,
pregnancy, and menopause can alter sleep architecture. Gender-related differences in …
pregnancy, and menopause can alter sleep architecture. Gender-related differences in …
Patient adherence and medical treatment outcomes: a meta-analysis
MR DiMatteo, PJ Giordani, HS Lepper… - Medical care, 2002 - journals.lww.com
Background. Adherence is a factor in the outcome of medical treatment, but the strength and
moderators of the adherence-outcome association have not been systematically assessed …
moderators of the adherence-outcome association have not been systematically assessed …
Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome
Background—Obstructive sleep apnea syndrome (OSAS), characterized by intermittent
hypoxia/reoxygenation (IHR), is an independent risk factor for cardiovascular disease. We …
hypoxia/reoxygenation (IHR), is an independent risk factor for cardiovascular disease. We …
Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders
CA Kushida, MR Littner, M Hirshkowitz… - Sleep, 2006 - academic.oup.com
Positive airway pressure (PAP) devices are used to treat patients with sleep related
breathing disorders (SRBD) including obstructive sleep apnea (OSA). Currently, PAP …
breathing disorders (SRBD) including obstructive sleep apnea (OSA). Currently, PAP …
Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome
N Mcardle, G Devereux, H Heidarnejad… - American journal of …, 1999 - atsjournals.org
Patients with the sleep apnea/hypopnea syndrome (SAHS) treated by nasal continuous
positive airway pressure (CPAP) need to use CPAP long-term to prevent recurrence of …
positive airway pressure (CPAP) need to use CPAP long-term to prevent recurrence of …
Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults
P Gay, T Weaver, D Loube, C Iber - Sleep, 2006 - academic.oup.com
Positive airway pressure (PAP) is used to treat obstructive sleep apnea (OSA), central sleep
apnea (CSA), and chronic hypoventilation. This document provides a systematic analysis …
apnea (CSA), and chronic hypoventilation. This document provides a systematic analysis …
Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS)
HM Engleman, MR Wild - Sleep medicine reviews, 2003 - Elsevier
Though continuous positive airway pressure (CPAP) is the treatment of choice for the sleep
apnoea/hypopnoea syndrome (SAHS), suboptimal adherence to CPAP is common …
apnoea/hypopnoea syndrome (SAHS), suboptimal adherence to CPAP is common …
The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients
Chronic obstructive pulmonary disease (COPD) patients with chronic ventilatory failure
(CVF) are more likely to develop exacerbations, which are an important determinant of …
(CVF) are more likely to develop exacerbations, which are an important determinant of …
Molecular signatures of obstructive sleep apnea in adults: a review and perspective
ES Arnardottir, M Mackiewicz, T Gislason, KL Teff… - Sleep, 2009 - academic.oup.com
The consequences of obstructive sleep apnea (OSA) are largely mediated by chronic
intermittent hypoxia and sleep fragmentation. The primary molecular domains affected are …
intermittent hypoxia and sleep fragmentation. The primary molecular domains affected are …